CONTACT US | Phone: 1-800-537-2790
  • COMPANY
    • OVERVIEW
    • QUALITY
    • CAREERS
  • PRODUCTS
    • RENUVION®
    • J-PLASMA®
    • PATENTS
    • SYMBOL GLOSSARY
    • Electronic IFU Portal
    • Electronic IFU Portal
  • INVESTOR RELATIONS
  • BLOG
  • COMPANY
    • OVERVIEW
    • QUALITY
    • CAREERS
  • PRODUCTS
    • RENUVION®
    • J-PLASMA®
    • PATENTS
    • SYMBOL GLOSSARY
    • Electronic IFU Portal
    • Electronic IFU Portal
  • INVESTOR RELATIONS
  • BLOG

Renuvion

Home » Renuvion » Page 3
By Nick Johnson (Apyx)
In 2024 Shareholder News, J-Plasma, Renuvion
Posted April 25, 2024

APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON MAY 9, 2024

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, Renuvion
Posted April 11, 2024

APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS’ SUMMIT

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, J-Plasma, Renuvion
Posted March 21, 2024

APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, J-Plasma, Renuvion
Posted March 4, 2024

APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS ON MARCH 21, 2024

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, Renuvion
Posted February 21, 2024

APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) SCIENTIFIC MEETING

READ MORE
By apyxmedical
In 2024 Shareholder News, J-Plasma, Renuvion
Posted January 22, 2024

APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, J-Plasma, Renuvion
Posted January 8, 2024

APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2023 REVENUE RESULTS

READ MORE
By Nick Johnson (Apyx)
In 2023 Shareholder News, J-Plasma, Renuvion
Posted November 28, 2023

APYX MEDICAL CORPORATION APPOINTS MATTHEW HILL AS CHIEF FINANCIAL OFFICER

READ MORE
By Nick Johnson (Apyx)
In 2023 Shareholder News, J-Plasma, Renuvion
Posted November 9, 2023

APYX MEDICAL CORPORATION ANNOUNCES NEW DEBT FACILITY WITH PERCEPTIVE ADVISORS

READ MORE
By Nick Johnson (Apyx)
In 2023 Shareholder News, J-Plasma, Renuvion
Posted November 9, 2023

APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND UPDATES FULL YEAR 2023 FINANCIAL OUTLOOK

READ MORE
1 2 3 4 5 6 7 8 9 ...
page 1 of 13

© Copyright 2024 Apyx Medical. All rights reserved. Renuvion®, J-Plasma® and Reshaping What's Possible® are registered trademarks of Apyx Medical Corporation. Bovie® is a registered trademark of Symmetry Surgical. Energy Elevating Lives℠ is a service mark of Apyx Medical Corporation. Apyx™ is a trademark of Apyx Medical Corporation.

Contact Us | Privacy Policy | Terms of Use | Disclaimer

Top
This site tracks visits anonymously. Visit our Privacy Policy page to learn more about the data we collect, and the cookies used on this site. If you agree with these policies, click the AGREE button to close this message.

AGREEPrivacy policy